How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

The ASCEND trial evaluated the safety, tolerability, and efficacy of solengepras and aimed to establish its potential to ...

A new Drosophila collection of Parkinsonism models reveals early synaptic cholinergic projection neuron dysfunction, linking synaptic failure to later dopaminergic decline, highlighting a role for ...

Obese people often experience less pleasure from eating, and UC Berkeley scientists may have discovered why: a decrease in a ...

The pivotal, Phase III study will evaluate the change in average daily “OFF” time in Parkinson's patients dosed with ...

This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...

Sanaa Eddiry embodies excellence and innovation in medical research. With over 15 years of experience, this pioneering ...

For the first time, scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility, according ...

Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present at AD/PD™ 2025 International ...

Paradoxically, some people cheat not because they feel disconnected, but because they feel too connected. For individuals ...

Canadian singer Grimes revealed she has been diagnosed with autism and ADHD, and suspects she has dyslexia. She discussed the ...

The world's best clinics achieve success in Parkinson’s treatment by individualizing deep brain stimulation (DBS) through ...